Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Minnerup

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
Der Nervenarzt|September 1, 2019
[Rare causes of stroke-a frequent stroke etiology]Antje Schmidt-Pogoda, Jens Minnerup
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 27, 2008
Multifunctional actions of approved and candidate stroke drugsJens Minnerup, Wolf-Rüdiger Schäbitz
Expert Opinion on Emerging Drugs|April 23, 2013
Emerging neuroprotective drugs for the treatment of acute ischaemic strokeAntje Schmidt, Jens Minnerup, Christoph Kleinschnitz
International Journal of Stroke : Official Journal of the International Stroke Society|February 5, 2026
Net Water Uptake (NWU) in Stroke Imaging: A Review of Applications in Patient Selection for Emerging Neuroprotective TherapiesGabriel Broocks, Jens Minnerup, André Kemmling
Experimental & Translational Stroke Medicine|February 10, 2010
Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studiesJens Minnerup, Sevgi Sevimli, Wolf-Rüdiger Schäbitz
Experimental & Translational Stroke Medicine|May 13, 2010
EPO for stroke therapy - Is there a future for further clinical development?Jens Minnerup, Heike Wersching, Wolf-Rüdiger Schäbitz
Therapeutic Advances in Neurological Disorders|March 6, 2019
Immunology of stroke: from animal models to clinical trialsAntje Schmidt-Pogoda, Jens Minnerup, Christoph Kleinschnitz
Hippocampus|December 8, 2010
Seeing old friends from a different angle: novel properties of hematopoietic growth factors in the healthy and diseased brainKai Diederich, Wolf-Rüdiger Schäbitz, Jens Minnerup
Critical Care (London, England)|March 23, 2011
Erythropoietin for stroke treatment: dead or alive?Jens Minnerup, Heike Wersching, Wolf-Rüdiger Schäbitz
Stroke|November 14, 2019
Checklists for Authors Improve the Reporting of Basic Science ResearchJens Minnerup, Ulrich Dirnagl, Wolf-Rüdiger Schäbitz
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
Der Nervenarzt|September 1, 2019
[Rare causes of stroke-a frequent stroke etiology]Antje Schmidt-Pogoda, Jens Minnerup
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 27, 2008
Multifunctional actions of approved and candidate stroke drugsJens Minnerup, Wolf-Rüdiger Schäbitz
Expert Opinion on Emerging Drugs|April 23, 2013
Emerging neuroprotective drugs for the treatment of acute ischaemic strokeAntje Schmidt, Jens Minnerup, Christoph Kleinschnitz
International Journal of Stroke : Official Journal of the International Stroke Society|February 5, 2026
Net Water Uptake (NWU) in Stroke Imaging: A Review of Applications in Patient Selection for Emerging Neuroprotective TherapiesGabriel Broocks, Jens Minnerup, André Kemmling
Experimental & Translational Stroke Medicine|February 10, 2010
Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studiesJens Minnerup, Sevgi Sevimli, Wolf-Rüdiger Schäbitz
Experimental & Translational Stroke Medicine|May 13, 2010
EPO for stroke therapy - Is there a future for further clinical development?Jens Minnerup, Heike Wersching, Wolf-Rüdiger Schäbitz
Therapeutic Advances in Neurological Disorders|March 6, 2019
Immunology of stroke: from animal models to clinical trialsAntje Schmidt-Pogoda, Jens Minnerup, Christoph Kleinschnitz
Hippocampus|December 8, 2010
Seeing old friends from a different angle: novel properties of hematopoietic growth factors in the healthy and diseased brainKai Diederich, Wolf-Rüdiger Schäbitz, Jens Minnerup
Critical Care (London, England)|March 23, 2011
Erythropoietin for stroke treatment: dead or alive?Jens Minnerup, Heike Wersching, Wolf-Rüdiger Schäbitz
Stroke|November 14, 2019
Checklists for Authors Improve the Reporting of Basic Science ResearchJens Minnerup, Ulrich Dirnagl, Wolf-Rüdiger Schäbitz
Pageof 19